Aptinib CAS No.811803-05-1
811803-05-1
Pharmaceutical grade
99%
Shanghai
JINLAN PHARM
25Kg/drum
2022-12-31
additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceApatinib free base (YN968D1 free base) is an orally bioavailable tyrosine kinase inhibitor, which selectively targets VEGFR-2 (IC50=1 nM). Apatinib free base (YN968D1 free base) is an anti-angiogenic drug for the treatment of advanced or metastatic gastric cancer. Apatinib free base (YN968D1 free base) potently inhibits Ret, c-Kit and c-Src with IC50s of 13, 429 and 530 nM, respectively. It also inhibits cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ[1][2][3].
Rivoceranib is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).|Rivoceranib is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. Upon administration, rivoceranib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.Basic Info-
Product Name:
N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide
Other Name:3-Pyridinecarboxamide,N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-;N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide;Rivoceranib;N-[4-(1-cyanocyclopentyl)phenyl]-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide;YN 968D1;1275609-09-0
CAS No.:811803-05-1
Molecular Formula:C24H23N5O
InChIKeys:InChIKey=WPEWQEMJFLWMLV-UHFFFAOYSA-N
Molecular Weight:397.47232
Exact Mass:397.47
EC Number:1592732-453-0
UNII:5S371K6132
DSSTox ID:DTXSID80153427
NCI Thesaurus Code:C152237
Categories:
Characteristics-
PSA:
90.7
Density:1.3±0.1 g/cm3
Boiling Point:578.2°C at 760 mmHg
Flash Point:303.5±30.1 °C
Refractive Index:1.652
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst
-
Location:
hangzhou,zhejiang
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
30 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2020
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Imeglimin CAS No.775351-65-0
Pharmaceutical grade / 99%
-
-
-
-
Ruxolitinib CAS No.941678-49-5
Pharmaceutical grade / 99%
-
-
-
-
Gadoterate Meglumine CAS No.92943-93-6
Pharmaceutical Grade / 99%
-
-
-
-
RU58841 CAS No.154992-24-2
Pharmaceutical grade / 99%
-
-
-
-
Sodium lauryl sulfoacetate (SLSA) CAS No.1847-58-1
Pharmaceutical grade / 99%
-
-
-
-
PEG-40 hydrogenated castor oil CAS No.61788-85-0
Pharmaceutical grade / 99%
-